IMAC

NASDAQ

IMAC Holdings Inc.

SectorHealth CareIndustryMedical SpecialitiesIPO2019

$1.01+0.09 (+9.76%)

News25/Ratings1

IMAC Holdings, Inc. owns, manages, and subleases a chain of innovative medical advancements and care regeneration centers in the United States. Its outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains. The company operates 16 outpatient clinics in Kentucky, Missouri, Tennessee, Illinois, and Florida. IMAC Holdings, Inc. was founded in 2000 and is based in Brentwood, Tennessee.

Latest news

25 items

1187d13D/G
SEC Form SC 13G filed by IMAC Holdings Inc.
SC 13G - IMAC Holdings, Inc. (0001729944) (Subject)
1257dSEC
SEC Form 10-Q filed by IMAC Holdings Inc.
10-Q - IMAC Holdings, Inc. (0001729944) (Filer)
1282dINSIDER
SEC Form 4: Sucoff Cary was granted 100,000 shares, increasing direct ownership by 100% to 200,000 units
4 - IMAC Holdings, Inc. (0001729944) (Issuer)
1282dINSIDER
SEC Form 4: Evans Maurice E. was granted 100,000 shares, increasing direct ownership by 89% to 212,420 units
4 - IMAC Holdings, Inc. (0001729944) (Issuer)
1282dINSIDER
SEC Form 4: Pruitt Michael D was granted 100,000 shares and covered exercise/tax liability with 37,000 shares, increasing direct ownership by 62% to 164,250 units
4 - IMAC Holdings, Inc. (0001729944) (Issuer)
1289dSEC
SEC Form EFFECT filed by IMAC Holdings Inc.
EFFECT - IMAC Holdings, Inc. (0001729944) (Filer)
1295dSEC
SEC Form S-3/A filed by IMAC Holdings Inc. (Amendment)
S-3/A - IMAC Holdings, Inc. (0001729944) (Filer)
1306dSEC
SEC Form S-3 filed by IMAC Holdings Inc.
S-3 - IMAC Holdings, Inc. (0001729944) (Filer)
1306dSEC
IMAC Holdings Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
8-K - IMAC Holdings, Inc. (0001729944) (Filer)
1323d13D/G
SEC Form SC 13G/A filed by IMAC Holdings Inc. (Amendment)
SC 13G/A - IMAC Holdings, Inc. (0001729944) (Subject)
1338dSEC
SEC Form D filed by IMAC Holdings Inc.
D - IMAC Holdings, Inc. (0001729944) (Filer)
1348dSEC
SEC Form 10-Q filed by IMAC Holdings Inc.
10-Q - IMAC Holdings, Inc. (0001729944) (Filer)
1348dSEC
IMAC Holdings Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Entry into a Material Definitive Agreement
8-K - IMAC Holdings, Inc. (0001729944) (Filer)
1348dSEC
SEC Form 424B5 filed by IMAC Holdings Inc.
424B5 - IMAC Holdings, Inc. (0001729944) (Filer)
1355dSEC
IMAC Holdings Inc. filed SEC Form 8-K: Financial Statements and Exhibits
8-K - IMAC Holdings, Inc. (0001729944) (Filer)
1361dNEWS
IMAC Holdings Announces NASDAQ Ticker Symbol Change From 'IMAC' To 'BACK'
IMAC Holdings, Inc. (Nasdaq: IMAC) ("IMAC" or the "Company"), will change its ticker symbol on the NASDAQ Stock Exchange from "IMAC" to "BACK" at the open of market trading on Monday, August 8, 2022.
1361dPR
IMAC Holdings, Inc. Announces NASDAQ Ticker Symbol Change from "IMAC" to "BACK"
BRENTWOOD, Tenn., Aug. 03, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) ("IMAC" or the "Company"), will change its ticker symbol on the NASDAQ Stock Exchange from "IMAC" to "BACK" at the open of market trading on Monday, August 8, 2022. "IMAC Holdings has developed a continuum of care for optimal spinal health, from the chiropractic wellness centers at the BackSpace to the IMAC Regeneration Centers' medical doctors, nurse practitioners, and physical therapists delivering advanced and innovative medical intervention," said Jeffrey Ervin, IMAC's Chief Executive Officer. "The spine is your body's central support structure and we recognize its importance for your overall health
1362dNEWS
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Allarity Therapeutics (NASDAQ:ALLR) stock rose 16.4% to $1.42 during Tuesday's pre-market session. The company's market cap stands at $13.1 million. Vaccinex (NASDAQ:VCNX) stock rose 12.91% to $1.15. The company's market cap stands at $49.1 million. Avalo Therapeutics (NASDAQ:AVTX) shares moved upwards by 12.49% to $4.05. The market value of their outstanding shares is at $38.0 million. Harmony Biosciences (NASDAQ:HRMY) shares moved upwards by 10.25% to $54.28. The market value of their outstanding shares is at $3.2 billion. As per the news, the Q2 earnings report came out today. Sonnet BioTherapeutics (NASDAQ:SONN) shares increased by 9.84% to $0.3. The company's market ca
1368dNEWS
Why Is F45 Training Holdings Down By 56%? Here Are 28 Stocks Moving In Wednesday's Pre-Market Session
Gainers Dave Inc. (NASDAQ:DAVE) rose 56.9% to $0.9826 in pre-market trading. Dave is expected to release its second quarter 2022 financial results on Thursday, August 11, 2022. Pzena Investment Management, Inc (NYSE:PZN) rose 46.4% to $9.43 in pre-market trading as the company said it has entered into an agreement to become a private company. The company also reported a rise quarterly sales. Teva Pharmaceutical Industries Limited (NYSE:TEVA) rose 18.3% to $8.42 in pre-market trading after the company reported better-than-expected financial results. Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) rose 18.1% to $0.31 in pre-market trading after declining more than 9% on Tuesday. AI
1368dNEWS
IMAC Holdings Shares Resume Trading; Shares Up ~12% For Session
1368dNEWS
IMAC Holdings Shares To Resume Trading At 9:50 a.m. EDT
1369dNEWS
IMAC Holdings Announces Exploration Of Strategic Alternatives To Maximize Shareholder Value
IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, today announced that its board of directors has initiated an exploration of strategic alternatives. As part of this process, the board will consider a wide range of options for the company including, among other things, a potential merger, spin-off, sale, or other strategic transaction for one or more of its key business units or assets. “As our company continues to expand into complementary revenue streams, we believe the time is right to investigate a range of strategic
1369dPR
IMAC Holdings Announces Exploration of Strategic Alternatives to Maximize Shareholder Value
BRENTWOOD, Tenn., July 26, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) ("IMAC" or the "Company"), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, today announced that its board of directors has initiated an exploration of strategic alternatives. As part of this process, the board will consider a wide range of options for the company including, among other things, a potential merger, spin-off, sale, or other strategic transaction for one or more of its key business units or assets. "As our company continues to expand into complementary revenue streams, we believe
1369dNEWS
IMAC Holdings Shares Halted; News Pending
1374dNEWS
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Addex Therapeutics (NASDAQ:ADXN) shares increased by 46.1% to $1.34 during Thursday's pre-market session. The company's market cap stands at $8.4 million. Tabula Rasa HealthCare (NASDAQ:TRHC) stock moved upwards by 14.61% to $2.98. The company's market cap stands at $77.0 million. MoonLake (NASDAQ:MLTX) stock rose 14.1% to $6.31. The market value of their outstanding shares is at $233.0 million. SELLAS Life Sciences Gr (NASDAQ:SLS) shares increased by 13.17% to $2.92. The market value of their outstanding shares is at $59.9 million. Olema Pharmaceuticals (NASDAQ:OLMA) shares increased by 10.4% to $5.2. The company's market cap stands at $209.8 million. Endo International (